Special Issue “Prostate Cancer: Recent Advances in Diagnostics and Treatment Planning”-Reference-Cited by-同舟云学术

Special Issue “Prostate Cancer: Recent Advances in Diagnostics and Treatment Planning”

Published:2022-11-18 Issue:22 Volume:11 Page:6823
ISSN:2077-0383
Container-title:Journal of Clinical Medicine
language:en
Short-container-title:JCM

Author:

Tokas Theodoros^ORCID

Abstract

This editorial of the Special Issue “Prostate Cancer: Recent Advances in Diagnostics and Treatment Planning” aims to draw more attention to the broad and diverse field of prostate cancer (PCa) diagnosis and the utilization of different diagnostic means to improve clinical decision-making and treatment strategy planning [...]

Publisher

MDPI AG

Subject

General Medicine

Link

https://www.mdpi.com/2077-0383/11/22/6823/pdf

Reference17 articles.

1. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent;Eur. Urol.,2021

2. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): A prospective, randomised, multicentre study;Lancet,2020

3. Precision Oncology for Metastatic Prostate Cancer: Translation into Practice;Eur. Urol.,2020

4. Oncologic Outcomes after Localized Prostate Cancer Treatment: Associations with Pretreatment Prostate Magnetic Resonance Imaging Findings;J. Urol.,2021

5. Venderbos, L.D., Luiting, H., Hogenhout, R., and Roobol, M.J. (2021). Interaction of MRI and active surveillance in prostate cancer: Time to re-evaluate the active surveillance inclusion criteria. Urol. Oncol.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 68Ga-prostate specific membrane antigen-11 PET/CT versus multiparametric MRI in the detection of primary prostate cancer: A systematic review and head-to-head comparative meta-analysis;European Journal of Radiology;2024-01